Last updated on July 2019

A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)

Brief description of study

This is a Phase 3, randomized, double-blind, placebo-controlled, multinational, and multicenter study to evaluate the efficacy of rovalpituzumab tesirine as maintenance therapy following first-line platinum-based chemotherapy.

Clinical Study Identifier: NCT03033511

Find a site near you

Start Over

Marin Cancer Care /ID# 159207

Greenbrae, CA United States
  Connect »

Ucsd /Id# 157764

La Jolla, CA United States
  Connect »

Icri /Id# 157765

Whittier, CA United States
  Connect »

Holy Cross Hospital /ID# 156716

Fort Lauderdale, FL United States
  Connect »

University of Florida /ID# 155799

Gainesville, FL United States
  Connect »

Billings Clinic /ID# 201788

Billings, MT United States
  Connect »

Cone Health /ID# 156689

Greensboro, NC United States
  Connect »

Cone Health /ID# 163612

Greensboro, NC United States
  Connect »

Inca /Id# 159658

Rio de Janeiro, Brazil
  Connect »

Iucpq /Id# 159530

Sainte-foy, QC Canada
  Connect »

PMI Euromedservice /ID# 159369

Pushkin, Russian Federation
  Connect »

LLC Novaya Clinica /ID# 205523

Pyatigorsk, Russian Federation
  Connect »

LLC BioEq Ltd. /ID# 159368

St. Petersburg, Russian Federation
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.